[NCCN2015]NCCN首席执行官Robert W. Carlson博士深入解读NCCN肿瘤临床实践指南——Robert W. Carlson博士访谈

作者:  R.W.Carlson   日期:2015/3/12 16:50:27  浏览量:80927

肿瘤瞭望版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

编者按:第20届NCCN年会即将于3月12日~14日在美国佛罗里达州好莱坞市召开。在会议开幕前一天,《肿瘤瞭望》前方记者采访了现任NCCN的首席执行官Robert W. Carlson博士,深入解读NCCN肿瘤临床实践指南,阐释NCCN指南与ASCO指南的差异,NCCN指南对中国患者是否适用等热点问题。Carlson博士还是斯坦福大学医学中心教授,著名乳腺癌专家,主持了多项大型临床试验。

 

  Oncology Frontier How do the NCCN Guidelines differ from the ASCO Guidelines?

 

  《肿瘤瞭望》: NCCN指南与ASCO指南有什么不同?

 

  Dr Carlson: The ASCO Guidelines and the NCCN Guidelines are actually quite complementary with each other. The ASCO Guidelines tend to be guidelines that focus on a relatively narrow apportion of patient care and look at great depth into the scientific evidence and information at the specific decision point or treatment type. The NCCN Guidelines are different in that they cover the continuum of care to the assessment of patient risk, to diagnosis, to treatment, to follow-up and survivorship after treatment and to end-of-life care. The NCCN Guidelines are continuous across that spectrum so that there is no decision that needs to be made that is not discussed in our guidelines. Because of that, our guidelines tend to be more useful at the point of patient care, while the ASCO Guidelines are guidelines that are in much greater depth and have their greatest value when a physician is trying to formally educate themselves but not necessarily at the point of care because the documents are just too extensive. So the two guidelines, from my perspective, are actually quite complementary.

 

  Carlson博士:ASCO指南和NCCN指南相互补充。ASCO指南专注于相对较窄的领域,深度分析特定决策点和治疗类型的科学证据和信息。而NCCN指南涵盖整个治疗过程(患者风险评估、诊断、治疗、随访、治疗后生存期、终末期护理),其内容是持续的,每个阶段患者需要做出决策都被NCCN指南涵盖。对于床旁诊疗(point of care)的医生而言NCCN指南更有用,ASCO指南更加深入,在医生们进修学习时更能发挥其最大价值。所以从我的角度来看,这两种指南实际上是相当互补的。

 

上一页  [1]  [2]  [3]  [4]  下一页

版面编辑:张楠  责任编辑:张彩琴

本内容仅供医学专业人士参考


NCCN指南ASCO指南NCCN年会NCCN肿瘤临床实践指南

分享到: 更多